Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Henry Ford Health System Blue Cross/Blue Shield of Michigan Foundation |
---|---|
Information provided by: | Henry Ford Health System |
ClinicalTrials.gov Identifier: | NCT00799695 |
Diabetic retinopathy is the major cause of blindness in working age Americans, and screening for it is cost-effective. There are a quarter of a million people in Southeast Michigan with diabetes and pre-diabetes.
Only half of patients with diabetes are screened regularly for diabetic retinopathy, and this proportion has been difficult to increase despite various interventions. Previous research focused on HMO patient groups because preventative care was thought to decrease plan costs. In addition, it was administratively feasible to track patient-doctor interactions.
This project builds on published research and institutional experience to determine an effective method for increasing the screening rate, in a mobile, non-HMO population. It uses administrative methods and information technology infrastructures, such as large scale electronic medical records and patient demographic databases, to identify existing patients requiring examinations.
Patients were telephoned by a trained service representative who offered and scheduled firm examination appointment times.
Hypothesis: Annual screening rates for diabetic retinopathy can be substantially improved in non-HMO patient groups by directly contacting patients and scheduling firm appointment times.
Condition | Intervention |
---|---|
Diabetic Retinopathy |
Behavioral: phone call contact |
Study Type: | Interventional |
Study Design: | Health Services Research, Randomized, Single Blind (Subject), Single Group Assignment, Efficacy Study |
Official Title: | Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population |
Enrollment: | 561 |
Study Start Date: | January 2008 |
Study Completion Date: | November 2008 |
Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Michigan | |
Henry Ford Health System | |
Detroit, Michigan, United States, 48202 |
Principal Investigator: | Robert M Levine,, MD | Henry Ford Health System |
Responsible Party: | Henry Ford Health System ( Robert M. Levine, MD ) |
Study ID Numbers: | F10030, F10030, 13.13PIRAP |
Study First Received: | November 26, 2008 |
Last Updated: | November 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00799695 History of Changes |
Health Authority: | United States: Institutional Review Board |
diabetic retinopathy screening annual |
Diabetic Retinopathy Eye Diseases Diabetes Mellitus Vascular Diseases Endocrine System Diseases |
Endocrinopathy Diabetes Complications Retinal Diseases Diabetic Angiopathies |
Diabetic Retinopathy Eye Diseases Diabetes Mellitus Vascular Diseases Endocrine System Diseases |
Cardiovascular Diseases Diabetes Complications Retinal Diseases Diabetic Angiopathies |